Heidelberg Pharma AG banner

Heidelberg Pharma AG
XBER:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
XBER:HPHA
Watchlist
Price: 2.39 EUR Market Closed
Market Cap: €111.4m

Dividends

Heidelberg Pharma AG
does not pay dividends

Shareholder Yield

Current shareholder yield for HPHA is hidden .

Shareholder Yield
LOCKED
Unlock
What is shareholder yield?
Dividend Yield
No dividends
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Price Appreciation

HPHA Price
Heidelberg Pharma AG

Annual Price Range
2.39
52w Low
2.31
52w High
4.9
Price Metrics
Average Annual Return -22.04%
Standard Deviation of Annual Returns 17.9%
Max Drawdown -75%
Shares Statistics
Market Capitalization 132.9m EUR
Shares Outstanding 46 604 977
Percentage of Shares Shorted
N/A

HPHA Return Decomposition
Main factors of price return

Stock Splits

HPHA's latest stock split occurred on Jul 18, 2014

The company executed a 1-for-4 stock split, meaning that for every 4 shares held, investors received 1 new share.

The adjusted shares began trading on Jul 18, 2014. This was the only stock split in HPHA's history.

Pre-Split Price
N/A
Post-Split Price
4.52
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett